173 related articles for article (PubMed ID: 29577645)
1. A novel monoclonal antibody KMP1 has potential antitumor activity of bladder cancer by blocking CD44 in vivo and in vitro.
Chen Y; Wang H; Zuo Y; Li N; Ding M; Li C
Cancer Med; 2018 May; 7(5):2064-2077. PubMed ID: 29577645
[TBL] [Abstract][Full Text] [Related]
2. BCMab1, a monoclonal antibody against aberrantly glycosylated integrin α3β1, has potent antitumor activity of bladder cancer in vivo.
Li C; Yang Z; Du Y; Tang H; Chen J; Hu D; Fan Z
Clin Cancer Res; 2014 Aug; 20(15):4001-13. PubMed ID: 25002124
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of CD44 expression by small interfering RNA to suppress the growth and metastasis of ovarian cancer cells in vitro and in vivo.
Li CZ; Liu B; Wen ZQ; Li HY
Folia Biol (Praha); 2008; 54(6):180-6. PubMed ID: 19393131
[TBL] [Abstract][Full Text] [Related]
4. A defucosylated anti‑CD44 monoclonal antibody 5‑mG2a‑f exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma.
Takei J; Kaneko MK; Ohishi T; Hosono H; Nakamura T; Yanaka M; Sano M; Asano T; Sayama Y; Kawada M; Harada H; Kato Y
Oncol Rep; 2020 Nov; 44(5):1949-1960. PubMed ID: 33000243
[TBL] [Abstract][Full Text] [Related]
5. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.
Song JM; Molla K; Anandharaj A; Cornax I; O Sullivan MG; Kirtane AR; Panyam J; Kassie F
Oncotarget; 2017 Apr; 8(16):26927-26940. PubMed ID: 28460475
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of tumor formation and metastasis by a monoclonal antibody against lymphatic vessel endothelial hyaluronan receptor 1.
Hara Y; Torii R; Ueda S; Kurimoto E; Ueda E; Okura H; Tatano Y; Yagi H; Ohno Y; Tanaka T; Masuko K; Masuko T
Cancer Sci; 2018 Oct; 109(10):3171-3182. PubMed ID: 30058195
[TBL] [Abstract][Full Text] [Related]
7. Carnosine exerts antitumor activity against bladder cancers in vitro and in vivo via suppression of angiogenesis.
Hwang B; Shin SS; Song JH; Choi YH; Kim WJ; Moon SK
J Nutr Biochem; 2019 Dec; 74():108230. PubMed ID: 31683101
[TBL] [Abstract][Full Text] [Related]
8. ppGalNAc T1 as a potential novel marker for human bladder cancer.
Ding MX; Wang HF; Wang JS; Zhan H; Zuo YG; Yang DL; Liu JY; Wang W; Ke CX; Yan RP
Asian Pac J Cancer Prev; 2012; 13(11):5653-7. PubMed ID: 23317233
[TBL] [Abstract][Full Text] [Related]
9. Triacanthine exerts antitumor effects on bladder cancer in vitro and in vivo.
Shin SS; Park YJ; Hwang B; Park SL; Han SW; Park SS; Choi YH; Kim WJ; Moon SK
Phytomedicine; 2019 Nov; 64():153069. PubMed ID: 31421400
[TBL] [Abstract][Full Text] [Related]
10. A Novel Therapeutic siRNA Nanoparticle Designed for Dual-Targeting CD44 and Gli1 of Gastric Cancer Stem Cells.
Yao H; Sun L; Li J; Zhou X; Li R; Shao R; Zhang Y; Li L
Int J Nanomedicine; 2020; 15():7013-7034. PubMed ID: 33061365
[TBL] [Abstract][Full Text] [Related]
11. A6 peptide activates CD44 adhesive activity, induces FAK and MEK phosphorylation, and inhibits the migration and metastasis of CD44-expressing cells.
Piotrowicz RS; Damaj BB; Hachicha M; Incardona F; Howell SB; Finlayson M
Mol Cancer Ther; 2011 Nov; 10(11):2072-82. PubMed ID: 21885863
[TBL] [Abstract][Full Text] [Related]
12. Androgen Receptor Regulates CD44 Expression in Bladder Cancer.
Sottnik JL; Vanderlinden L; Joshi M; Chauca-Diaz A; Owens C; Hansel DE; Sempeck C; Ghosh D; Theodorescu D
Cancer Res; 2021 Jun; 81(11):2833-2846. PubMed ID: 33687952
[TBL] [Abstract][Full Text] [Related]
13. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
[TBL] [Abstract][Full Text] [Related]
14. CD44 Isoform Status Predicts Response to Treatment with Anti-CD44 Antibody in Cancer Patients.
Birzele F; Voss E; Nopora A; Honold K; Heil F; Lohmann S; Verheul H; Le Tourneau C; Delord JP; van Herpen C; Mahalingam D; Coveler AL; Meresse V; Weigand S; Runza V; Cannarile M
Clin Cancer Res; 2015 Jun; 21(12):2753-62. PubMed ID: 25762343
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor effect against human cancer xenografts by a fully human monoclonal antibody to a variant 8-epitope of CD44R1 expressed on cancer stem cells.
Masuko K; Okazaki S; Satoh M; Tanaka G; Ikeda T; Torii R; Ueda E; Nakano T; Danbayashi M; Tsuruoka T; Ohno Y; Yagi H; Yabe N; Yoshida H; Tahara T; Kataoka S; Oshino T; Shindo T; Niwa S; Ishimoto T; Baba H; Hashimoto Y; Saya H; Masuko T
PLoS One; 2012; 7(1):e29728. PubMed ID: 22272243
[TBL] [Abstract][Full Text] [Related]
16. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
[TBL] [Abstract][Full Text] [Related]
17. Platycodin D (PD) regulates LncRNA-XIST/miR-335 axis to slow down bladder cancer progression in vitro and in vivo.
Chen D; Chen T; Guo Y; Wang C; Dong L; Lu C
Exp Cell Res; 2020 Nov; 396(1):112281. PubMed ID: 32919956
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of doxorubicin-monoclonal antibody conjugate on human bladder cancer.
Yu DS; Chu TM; Yeh MY; Chang SY; Ma CP; Han SH
J Urol; 1988 Aug; 140(2):415-21. PubMed ID: 3398165
[TBL] [Abstract][Full Text] [Related]
19. B7‑H3 promotes malignant progression of muscle‑invasive bladder cancer.
Xu ZL; Zhang Y; Wang L; Li F; Man HW; Li PF; Shan BE
Oncol Rep; 2018 Nov; 40(5):2722-2733. PubMed ID: 30132557
[TBL] [Abstract][Full Text] [Related]
20. A novel target anti-interleukin-13 receptor subunit alpha-2 monoclonal antibody inhibits tumor growth and metastasis in lung cancer.
Raza G; Yunus FU; Mangukiya HB; Merugu SB; Mashausi DS; Zeling W; Negi H; Zhou B; Roy D; Wu Z; Li D
Int Immunopharmacol; 2021 Jan; 90():107155. PubMed ID: 33243603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
